Assessment of anticoagulant safety and coagulation analysis in mice using the VETSCAN VSpro analyzer

Faqi AS (2016) A comprehensive guide to toxicology in nonclinical drug development. https://doi.org/10.1016/C2015-0-00147-2

Emeis JJ, Jirouskova M, Muchitsch EM, Shet AS, Smyth SS, Johnson GJ (2007) A guide to murine coagulation factor structure, function, assays, and genetic alterations. J Thromb Haemost 5(4):670–679. https://doi.org/10.1111/j.1538-7836.2007.02408.x

Article  CAS  PubMed  Google Scholar 

Mohammed BM, Monroe DM, Gailani D (2020) Mouse models of hemostasis. Platelets 31(4):417–422. https://doi.org/10.1080/09537104.2020.1719056

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ripsman D, Fergusson DA, Montroy J, Auer RC, Huang JW, Dobriyal A et al (2020) A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models. Thromb Res 195:103–113. https://doi.org/10.1016/j.thromres.2020.07.008

Article  CAS  PubMed  Google Scholar 

Dixon-Jimenez AC, Brainard BM, Cathcart CJ, Koenig A (2013) Evaluation of a point-of-care coagulation analyzer (Abaxis VSPro) for identification of coagulopathies in dogs. J Vet Emerg Crit Care (San Antonio) 23(4):402–407. https://doi.org/10.1111/vec.12064

Article  PubMed  Google Scholar 

Condrey JA, Flietstra T, Nestor KM, Schlosser EL, Coleman-McCray JD, Genzer SC et al (2020) Prothrombin time, activated partial thromboplastin time, and fibrinogen reference intervals for inbred strain 13/N Guinea Pigs (Cavia porcellus) and Validation of low volume sample analysis. microorganisms 8(8). https://doi.org/10.3390/microorganisms8081127

Jesus SA, Schmidt A, Fickel J, Doherr MG, Boonprasert K, Thitaram C et al (2022) Assessing coagulation parameters in healthy asian elephants (Elephas maximus) from european and thai populations. anim (Basel) 12(3). https://doi.org/10.3390/ani12030361

Nevitt BN, Chinnadurai SK, Watson MK, Langan JN, Adkesson MJ (2016) Prothrombin time and activated partial thromboplastin time using a point-of-care analyser (Abaxis VSpro®) in Bennett’s wallabies (Macropus rufogriseus). Aust Vet J 94(10):384–386. https://doi.org/10.1111/avj.12489

Article  CAS  PubMed  Google Scholar 

Epstein KL, Brainard BM (2012) An evaluation of the Abaxis VSPro for the measurement of equine plasma fibrinogen concentrations. Equine Vet J 44(4):449–452. https://doi.org/10.1111/j.2042-3306.2011.00453.x

Article  CAS  PubMed  Google Scholar 

Hubrecht R (2013) Revised Australian Code for the care and use of animals for scientific purposes. Anim Welf 22(4):491

Article  Google Scholar 

Buijs JT, Laghmani EH, van den Akker RFP, Tieken C, Vletter EM, van der Molen KM et al (2019) The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice. J Thromb Haemost 17(6):951–963. https://doi.org/10.1111/jth.14443

Article  PubMed  PubMed Central  Google Scholar 

Pesei ZG, Jancsó Z, Demcsák A, Németh BC, Vajda S, Sahin-Tóth M (2022) Preclinical testing of dabigatran in trypsin-dependent pancreatitis. JCI Insight 7(21). https://doi.org/10.1172/jci.insight.161145

Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM (2007) VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 6(9):1449–1454. https://doi.org/10.4161/cbt.6.9.4622

Article  PubMed  Google Scholar 

Obi AT, Sharma SB, Elfline MA, Luke CE, Dowling AR, Cai Q et al (2023) Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions. Sci Rep 13(1):3253. https://doi.org/10.1038/s41598-023-30149-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peters LL, Cheever EM, Ellis HR, Magnani PA, Svenson KL, Von Smith R, Bogue MA (2002) Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol Genomics 11(3):185–193. https://doi.org/10.1152/physiolgenomics.00077.2002

Article  CAS  PubMed  Google Scholar 

Mendenhall M, Russell A, Smee DF, Hall JO, Skirpstunas R, Furuta Y, Gowen BB (2011) Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever. PLoS Negl Trop Dis 5(10):e1342. https://doi.org/10.1371/journal.pntd.0001342

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif